Human pregnane X receptor and sexual dimorphism in alcoholic liver disease
人类孕烷X受体与酒精性肝病中的性别二态性
基本信息
- 批准号:10100621
- 负责人:
- 金额:$ 33.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-20 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AODR mortalityAcetaldehydeAddressAffectAfrican AmericanAlcohol consumptionAlcoholic Liver DiseasesAlcoholic steatohepatitisAlcoholsAllelesAnimal ModelApoptosisBiological AssayBloodBlood specimenCYP2B6 geneCaucasiansCell DeathCellsChemicalsChronicClinical ResearchDNA FragmentationDNA LibraryDataDeath RateDevelopmentDiseaseDoseDrug KineticsDrug Metabolic DetoxicationEstrogensEthanolEthanol MetabolismExpression ProfilingFatty acid glycerol estersFemaleGene ExpressionGene FrequencyGenerationsGenesGenetic PolymorphismGenetic TranscriptionGenomic DNAGenotypeHepaticHepatocyteHepatotoxicityHomologous GeneHumanInterventionIntestinesKnockout MiceLipidsLiverMediatingMessenger RNAMetabolicMetabolic DiseasesModelingMusNuclearNuclear ReceptorsOrthologous GenePPAR gammaPathogenesisPathologicPathologyPatientsPharmaceutical PreparationsPharmacologyProductionProteinsReactive Oxygen SpeciesReceptor GeneReceptor SignalingRegulationReportingRodentRoleSex DifferencesSignal TransductionSingle Nucleotide PolymorphismTestingTissuesUp-RegulationVariantWild Type MouseWomanXenobioticsalcohol exposurebaseclinically relevantconstitutive androstane receptordiagnostic biomarkerdisorder riskethnic differencefeedinghuman tissuehumanized mouseinsightlipid biosynthesisliver injurymalemenmetabolomicsmouse modelnovelnovel diagnosticspregnane X receptorproblem drinkersexsexual dimorphismsmall hairpin RNAspecific biomarkerstherapeutic targettranscription factor
项目摘要
Title: Human pregnane X receptor and sexual dimorphism in alcoholic liver disease.
Abstract: Alcoholic liver disease (ALD) develops from excessive alcohol use and is more severe in both human
and rodent females than their male counterparts. Female alcoholics also have higher death rate than men.
Several mechanisms have been proposed to account for more severe ALD in females, including sex differences
in ethanol (EtOH) pharmacokinetics, estrogen levels, and alcohol elimination rates. However, the precise
mechanism(s) is/are not well understood, although there are recent indications that suggest complexities in both
ALD sexual dimorphism and ALD pathogenesis. For example, the upregulation of murine hepatic fat-specific
protein 27 (Fsp27) and its human ortholog, cell death-inducing DNA fragmentation factor alpha-like effector c
(CIDEC), which have been previously implicated in metabolic disorders and cell apoptosis, promote a
progressive form of ALD, alcoholic steatohepatitis (ASH) in both mice and human patients with ASH. However,
whether EtOH hepatotoxicity in females involves Fsp27 upregulation is unknown. FSP27 is a target gene of the
lipogenic transcription factor peroxisome proliferator-activated receptor γ (PPARγ) and inhibition of PPARγ
ameliorates ASH in mice. Upstream, PPARγ is transcriptionally regulated by pregnane X receptor (PXR), a
xenobiotic nuclear receptor that induces genes involved in the detoxification of drugs and other foreign
chemicals. We have previously shown that mouse PXR exacerbates EtOH-induced hepatotoxicity. Therefore,
we asked whether human PXR signaling similarly modulates the PPARγ-FSP27 signaling axis in EtOH
hepatotoxicity, particularly, focusing on sex differences in ALD. Unexpectedly, we found that chronic-plus-binge
EtOH ingestion upregulated both PPARγ and FSP27 in a sex-dependent manner in a PXR-humanized (hPXR)
mice, lacking the mouse Pxr gene, but carrying the full human PXR gene. Furthermore, the nuclear constitutive
androstane receptor (CAR) and PXR target gene, Cyp2b10, known to generate reactive oxygen species, was
also increased in the livers of EtOH-fed female hPXR mice. Thus, our central hypothesis is that the female
hPXR gene mediates sexual dimorphism in EtOH hepatotoxicity via increased lipogenesis and
synergistic generation of reactive oxygen species (ROS) by enhanced Fsp27 and Cyp2b10 gene
expression. To address these hypotheses, we will determine the contribution of the PXR-PPARγ-FSP27
signaling axis to female-specific ALD pathology (Aim 1). determine whether CYP2B6 induction is
involved in female-specific EtOH-induced hepatotoxicity (Aim 2). determine the contribution of PXR,
PPARγ, CYP2B6, and CIDEC genetic polymorphisms to sex and ethnic differences in ALD (Aim 3). A
strength of this proposal is that, it makes use of humanized mice and human tissues from both sexes, expediting
application to clinical studies. Based on our strong preliminary data, this proposal will provide valuable insights
into how sex and species-specific regulation of PXR target genes, as well as specific biomarkers from
metabolomics contribute to sex difference in EtOH-induced hepatotoxicity, which may identify therapeutic targets
for the treatment of ALD.
标题:人类孕烷X受体与酒精性肝病的性二型性。
摘要:酒精性肝病(ALD)是由过量饮酒引起的,在人类和人类中都更为严重。
和雌性啮齿类动物相比,它们的雄性同行。女性酗酒者的死亡率也高于男性。
已经提出了几种机制来解释女性更严重的ALD,包括性别差异
乙醇(Etoh)的药代动力学、雌激素水平和酒精清除率。然而,准确的
机制(S)还不是很清楚,尽管最近的迹象表明两者都很复杂
ALD性二型性与ALD发病机制例如,小鼠肝脏脂肪特异性的上调
蛋白27(Fsp27)及其人类同源基因--细胞死亡诱导DNA碎片因子α样效应子c
(CIDEC)以前被认为与代谢紊乱和细胞凋亡有关,它促进一种
进行性酒精性脂肪性肝炎(ASH),在小鼠和人类ASH患者中都是如此。然而,
乙醇对女性的肝毒性是否与Fsp27上调有关尚不清楚。FSP27是人类免疫缺陷病毒的靶基因。
生脂转录因子过氧化体增殖物激活受体γ(γ)及其γ的抑制
改善小鼠的灰质。上游,PPARγ受孕烷X受体(PxR)转录调控,a
异种生物核受体,诱导参与药物和其他外来物质解毒的基因
化学制品。我们之前已经证明,小鼠PXR加剧了乙醇诱导的肝毒性。因此,
我们询问人类PXR信号是否类似地调制无水乙醇中的PPARγ-FSP27信号轴
肝毒性,尤其关注ALD的性别差异。出乎意料的是,我们发现慢性+狂欢
乙醇摄入以一种性别依赖的方式上调PPARγ和FSP27
小鼠,缺乏小鼠PXR基因,但携带完整的人PXR基因。此外,核的本构关系
雄烷受体(CAR)和PXR靶基因Cyp2b10是已知的产生活性氧物种的基因。
在喂食乙醇的雌性hPXR小鼠的肝脏中也有增加。因此,我们的中心假设是,女性
HPXR基因介导乙醇肝毒性中的性别二型性通过增加脂肪生成和
增强型Fsp27和Cyp2b10基因协同产生ROS
表情。为了解决这些假设,我们将确定PXR-PPARγ-FSP27的贡献
信号轴到女性特有的ALD病理(目标1)。确定CYP2B6诱导是否为
参与女性特异性乙醇所致的肝毒性(目标2)。确定PXR的贡献,
PPARγ、CYP2B6和CIDEC基因多态性与肌萎缩侧索硬化症的性别和种族差异(目标3)。一个
这一提议的优点在于,它利用了人源化的老鼠和两性的人体组织,加快了
应用于临床研究。基于我们强大的初步数据,这项建议将提供有价值的见解
PXR的性别和物种特异性调控如何针对基因以及特定的生物标记物
代谢组学有助于乙醇肝毒性的性别差异,这可能确定治疗靶点
用于治疗酒精性肝病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maxwell Afari Gyamfi其他文献
Maxwell Afari Gyamfi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maxwell Afari Gyamfi', 18)}}的其他基金
Human pregnane X receptor and sexual dimorphism in alcoholic liver disease
人类孕烷X受体与酒精性肝病中的性别二态性
- 批准号:
10577359 - 财政年份:2022
- 资助金额:
$ 33.3万 - 项目类别:
Human pregnane X receptor and sexual dimorphism in alcoholic liver disease
人类孕烷X受体与酒精性肝病中的性别二态性
- 批准号:
10443826 - 财政年份:2022
- 资助金额:
$ 33.3万 - 项目类别:
Human pregnane X receptor and sexual dimorphism in alcoholic liver disease
人类孕烷X受体与酒精性肝病中的性别二态性
- 批准号:
10659135 - 财政年份:2022
- 资助金额:
$ 33.3万 - 项目类别:
Human pregnane X receptor and sexual dimorphism in alcoholic liver disease
人类孕烷X受体与酒精性肝病中的性别二态性
- 批准号:
10265520 - 财政年份:2020
- 资助金额:
$ 33.3万 - 项目类别:
Project 3: Role of pregnane X receptor in diet-induced obesity and metabolic syndrome
项目3:孕烷X受体在饮食引起的肥胖和代谢综合征中的作用
- 批准号:
10204741 - 财政年份:2017
- 资助金额:
$ 33.3万 - 项目类别:
Project 3: Role of pregnane X receptor in diet-induced obesity and metabolic syndrome
项目3:孕烷X受体在饮食引起的肥胖和代谢综合征中的作用
- 批准号:
9977716 - 财政年份:2017
- 资助金额:
$ 33.3万 - 项目类别:
Project 3: Role of pregnane X receptor in diet-induced obesity and metabolic syndrome
项目3:孕烷X受体在饮食引起的肥胖和代谢综合征中的作用
- 批准号:
9450138 - 财政年份:
- 资助金额:
$ 33.3万 - 项目类别:
Project 3: Role of pregnane X receptor in diet-induced obesity and metabolic syndrome
项目3:孕烷X受体在饮食引起的肥胖和代谢综合征中的作用
- 批准号:
9750533 - 财政年份:
- 资助金额:
$ 33.3万 - 项目类别:
相似海外基金
An enzyme-based assay for the detection of acetaldehyde-protein adducts
用于检测乙醛-蛋白质加合物的酶测定法
- 批准号:
10760201 - 财政年份:2023
- 资助金额:
$ 33.3万 - 项目类别:
Dissecting the role of acetaldehyde in oral carcinogenesis
剖析乙醛在口腔癌发生中的作用
- 批准号:
10345780 - 财政年份:2022
- 资助金额:
$ 33.3万 - 项目类别:
Dissecting the role of acetaldehyde in oral carcinogenesis
剖析乙醛在口腔癌发生中的作用
- 批准号:
10706454 - 财政年份:2022
- 资助金额:
$ 33.3万 - 项目类别:
Identification of mutation patterns induced by acetaldehyde exposure
乙醛暴露引起的突变模式的鉴定
- 批准号:
20K17047 - 财政年份:2020
- 资助金额:
$ 33.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RUI: Collaborative: Cycling of ethanol and acetaldehyde in coastal waters
RUI:合作:沿海水域乙醇和乙醛的循环
- 批准号:
2022184 - 财政年份:2020
- 资助金额:
$ 33.3万 - 项目类别:
Standard Grant
Reconsideration of the drinking habit of alcoholic liver disease patients from the viewpoint of acetaldehyde-derived advanced glycation end products
从乙醛衍生晚期糖基化终末产物角度重新思考酒精性肝病患者饮酒习惯
- 批准号:
19K11803 - 财政年份:2019
- 资助金额:
$ 33.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathogenic Role of Malondialdehyde-Acetaldehyde Adducts in Rheumatoid Arthritis
丙二醛-乙醛加合物在类风湿性关节炎中的致病作用
- 批准号:
10421254 - 财政年份:2019
- 资助金额:
$ 33.3万 - 项目类别:
Pathogenic Role of Malondialdehyde-Acetaldehyde Adducts in Rheumatoid Arthritis
丙二醛-乙醛加合物在类风湿性关节炎中的致病作用
- 批准号:
10045500 - 财政年份:2019
- 资助金额:
$ 33.3万 - 项目类别:
Pathogenic Role of Malondialdehyde-Acetaldehyde Adducts in Rheumatoid Arthritis
丙二醛-乙醛加合物在类风湿性关节炎中的致病作用
- 批准号:
10516090 - 财政年份:2019
- 资助金额:
$ 33.3万 - 项目类别:
Analysis of the molecular mechanism to repair acetaldehyde-induced DNA damage
修复乙醛所致DNA损伤的分子机制分析
- 批准号:
17K17846 - 财政年份:2017
- 资助金额:
$ 33.3万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




